Published in Hematology Week, May 26th, 2008
"The review also presents the best data for long-term outcome, clinical markers of prognosis, and the results of randomized controlled trials. Our...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.